HIGHLIGHTS
- who: ufeffGabrielle M.ufeff ufeffMeyufeff and ufeffTara M.ufeff ufeffDeSilvaufeff from the Japan The University of Sydney have published the Article: Utility of the visual system to monitor neurodegeneration in multiple sclerosis, in the Journal: (JOURNAL)
- future: In a substudy of the opicinumab (RENEW) trial mfVEP was used as a readout instead of full-field VEP and showed that mfVEP may be a more sensitive way to assess remyelination in future studies (Klistorner et_al 2018).
SUMMARY
Visual system pathology is evident in both MS (Fisher et_al, 2006; Green et_al, 2010; Albrecht . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.